Dhingra Ankur — SEC Form 4 filings
SEC reporting owner CIK 1849682. 5 Form 4 filings on record with FilingPulse; latest filed 2026-03-09.
Transaction summary — filings shown
Covers all 5 filings on record, filed 2024-03-27 to 2026-03-09. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): 2 legs across 2 filings — 106,100 shares, $870,381 total (shares × price as filed).
- Open-market sales (code S, non-derivative): none reported.
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 9.
- Largest priced transaction: purchase of 6,100 shares @ $81.21 ($495,381) in ILLUMINA, INC., filed 2025-05-14.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| ILLUMINA, INC. (ILMN) | SVP, Chief Financial Officer | 4 | 1 leg · 6,100 sh · $495,381 | — | 9 |
| Summit Therapeutics Inc. (SMMT) | Chief Financial Officer | 1 | 1 leg · 100,000 sh · $375,000 | — | — |
Form 4 filings — Dhingra Ankur
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-03-09 | 4 | ILLUMINA, INC. (ILMN) | Grant/award (A): 9,358 @ $128.24 · Grant/award (A): 10,918 (derivative) @ $128.24 · Grant/award (A): 10,918 (derivative) @ $128.24 | EDGAR |
| 2025-05-14 | 4 | ILLUMINA, INC. (ILMN) | Purchase (P): 6,100 @ $81.21 | EDGAR |
| 2025-03-07 | 4 | ILLUMINA, INC. (ILMN) | Grant/award (A): 9,803 @ $0 · Grant/award (A): 11,437 (derivative) @ $0 · Grant/award (A): 11,437 (derivative) @ $0 | EDGAR |
| 2024-05-08 | 4 | ILLUMINA, INC. (ILMN) | Grant/award (A): 8,826 @ $0 · Grant/award (A): 10,296 (derivative) @ $0 · Grant/award (A): 10,296 (derivative) @ $0 | EDGAR |
| 2024-03-27 | 4 | Summit Therapeutics Inc. (SMMT) | Purchase (P): 100,000 @ $3.75 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1849682 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →